Zobrazeno 1 - 10
of 142
pro vyhledávání: '"N. J. Espat"'
Publikováno v:
Sarcoma, Vol 4, Iss 4, Pp 173-177 (2000)
Purpose. Angiosarcoma is a rare tumor with endothelial cell differentiation that may arise in any anatomic location.The purpose of this report was to identify prognostic factors on outcome in a group of prospectively followed patients with confirm
Externí odkaz:
https://doaj.org/article/c8890bd0f06a48f4be002f758fc79d15
Autor:
Marissa Cunetta, N J Espat, George Miller, Richard P. Junghans, Mitchell Thorn, Steven C. Katz, Prajna Guha
Publikováno v:
Cancer Gene Therapy. 23:188-198
Assumptions that liver immune cells and immunosuppressive pathways are similar to their counterparts in other spaces have led to gaps in our understanding of intrahepatic neoplasm aggressiveness. Myeloid-derived suppressor cells (MDSCs) are potent in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b410560acde24c93fe25ed6ae2f6c38
https://doi.org/10.1038/cgt.2016.19
https://doi.org/10.1038/cgt.2016.19
Autor:
Gary Point, Steven C. Katz, Richard P. Junghans, N J Espat, Cherif Boutros, Nader Hanna, Marissa Cunetta, Prajna Guha, Mitchell Thorn
Publikováno v:
Cancer gene therapy
Metastatic spread of colorectal cancer (CRC) to the peritoneal cavity is common and difficult to treat, with many patients dying from malignant bowel obstruction. Chimeric antigen receptor T cell (CAR-T) immunotherapy has shown great promise, and we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043eda6881d6f4bf4694ff5f02d0b65f
https://doi.org/10.1038/cgt.2016.14
https://doi.org/10.1038/cgt.2016.14
Autor:
Mitchell Thorn, Robin Davies, Brian F. Stainken, Abdul Saied, Elise McCormack, Richard P. Junghans, E O Assanah, Lauren A. Licata, N J Espat, Steven C. Katz, Rachel A. Burga, P D Khare
Publikováno v:
Cancer gene therapy
Our phase I Hepatic Immunotherapy for Metastases (HITM) trial tested the safety of chimeric antigen receptor-modified T-cell (CAR-T) hepatic artery infusions (HAI) for unresectable carcinoembryonic antigen (CEA)+ liver metastases (LM). High neutrophi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe78db5b22a9ca2e8717f8b2937eaf2
https://doi.org/10.1038/cgt.2014.50
https://doi.org/10.1038/cgt.2014.50
Autor:
Jesus Esquivel, Paul F. Mansfield, Jason M. Foster, Daniel M. Labow, T. Blazer, Robert M. Barone, Joseph J. Skitzki, Richard E. Royal, John H. Stewart, J. Spellman, Robert P. Sticca, Benjamin D.L. Li, James F. Pingpank, Laura A. Lambert, George I. Salti, H.R. Alexander, Edward A. Levine, Reynaldo Garcia, A. Bastidas, N. J. Espat, Lawrence E. Harrison, F. Attiyeh, Armando Sardi, K. Y. Chung, Richard A. Hoefer, Andrew M. Lowy, R. Adbel-Misih, Colette R. Pameijer, M. Quinones, Garrett M. Nash, Quyen D. Chu, E. Ong, Keith Fournier, Kiran K. Turaga, Michael D. Goodman, Perry Shen, Nader Hanna, John M. Kane, Matthew P. Holtzman, Michael A. Morse, David L. Bartlett, L. Dominguez-Parra, Nicholas J. Petrelli
Publikováno v:
Annals of Surgical Oncology. 21:1501-1505
The American Society of Peritoneal Surface Malignancies (ASPSM) is a consortium of cancer centers performing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). This is a position paper from the ASPSM on the standardization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d48f92a6e6a3d379c4042f48fb8a75a3
https://doi.org/10.1245/s10434-013-3061-z
https://doi.org/10.1245/s10434-013-3061-z
Autor:
Min, Lingqiang1 (AUTHOR), Liu, Zheng2,3 (AUTHOR), Zhou, Bo4 (AUTHOR), Zhou, Peng3 (AUTHOR), Luo, Rongkui5 (AUTHOR), Ding, Yuqin6 (AUTHOR), Cui, Yuehong7 (AUTHOR), Shi, Zhongyi3 (AUTHOR), Gu, Yuan3 (AUTHOR), Sun, Yihong8,9 (AUTHOR), Tang, Zhaoqing3,9 (AUTHOR) tang.zhaoqing@zs‐hospital.sh.cn, Wang, Xuefei3,9 (AUTHOR) wang.xuefei@zs‐hospital.sh.cn
Publikováno v:
Cancer Medicine. Nov2024, Vol. 13 Issue 21, p1-10. 10p.
Autor:
Maria V. Gorodner, Carlos A. Galvani, F. Moser, N. J. Espat, Phillip Donahue, C. Chretien, Garth R. Jacobsen, Santiago Horgan
Publikováno v:
Surgical Endoscopy. 22:188-195
Esophagectomy is a technically demanding operation with high procedure-related morbidity and mortality rates. Minimally invasive techniques were introduced in the late 1980s in an effort to decrease the invasiveness of the procedure. Data concerning
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62afc05ec883e94acdb94ba5ccd97eb5
https://doi.org/10.1007/s00464-007-9441-3
https://doi.org/10.1007/s00464-007-9441-3
Autor:
Steven J. Katz, Matthew Lima, Prajna Guha, N J. Espat, Zhi Liu, Josephine Darpolor, Gary Point, Marissa Cunetta, Jillian Gardell
Publikováno v:
Cancer Research. 76:2213-2213
We previously tested the efficacy of chimeric antigen receptor T cell (CAR-T) treatment via hepatic artery infusion in a phase I clinical trial. Though these results were promising, our current protocol for hepatic immunotherapy for metastasis (HITM)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b4f4ddaac1689ef3b2e7bbe523a216b
https://doi.org/10.1158/1538-7445.am2016-2213
https://doi.org/10.1158/1538-7445.am2016-2213
Autor:
Steven C. Katz, Marissa Cunetta, Ponnandai Somasundar, Richard P. Junghans, N. J. Espat, Prajna Guha
Publikováno v:
Cancer Research. 76:2212-2212
Chimeric antigen receptors expressing T cells (CAR-Ts) are a promising form of immunotherapy for solid tumors. The majority of cancer patients in the United States are over 65 years old. The impact of age-related physiologic changes on cancer therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c192409a9092ce82bd22c7469a7899f
https://doi.org/10.1158/1538-7445.am2016-2212
https://doi.org/10.1158/1538-7445.am2016-2212
Autor:
N. J. Espat, Gary Point, Marissa Cunetta, Zhi Liu, Josephine Darpolor, Richard P. Junghans, Cherif Boutros, Nader Hanna, Prajna Guha, Steven J. Katz, Matthew Lima
Publikováno v:
Cancer Research. 76:2301-2301
Colorectal carcinomatosis due to peritoneal metastases (PM) is a significant cause of morbidity and mortality. Present treatments fail to cure the majority of patients with PM. We are developing a chimeric antigen receptor T cell (CAR-T) regional inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34c2f4629ad765bda23bbe037ac03c79
https://doi.org/10.1158/1538-7445.am2016-2301
https://doi.org/10.1158/1538-7445.am2016-2301